Literature DB >> 8169387

Spread of Vibrio cholerae O139 Bengal in India.

G B Nair1, T Ramamurthy, S K Bhattacharya, A K Mukhopadhyay, S Garg, M K Bhattacharya, T Takeda, T Shimada, Y Takeda, B C Deb.   

Abstract

Vibrio cholerae serogroup O139 Bengal, a novel strain with epidemic potential, completely displaced V. cholerae serogroup 01 in Calcutta in January 1993, which was followed by an epidemic caused by V. cholerae O139 in March-May 1993. From November 1992 to July 1993, 95.6% of 916 V. cholerae isolates submitted to the National Institute of Cholera and Enteric Diseases from 28 locations in India were confirmed as serogroup O139. As of July 1993, V. cholerae O139 had been isolated from 13 Indian states and a union territory, and large outbreaks of cholera caused by the O139 serogroup had occurred in several cities. The extent of spread of V. cholerae O139 Bengal in India and its ability to swiftly disseminate leaves little doubt that this is the beginning of the eighth pandemic of cholera.

Entities:  

Mesh:

Year:  1994        PMID: 8169387     DOI: 10.1093/infdis/169.5.1029

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  51 in total

1.  Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139.

Authors:  Stephen R Attridge; Camilla Johansson; Dang D Trach; Firdausi Qadri; Ann-Mari Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Seasonal cholera caused by Vibrio cholerae serogroups O1 and O139 in the coastal aquatic environment of Bangladesh.

Authors:  Munirul Alam; Nur A Hasan; Abdus Sadique; N A Bhuiyan; Kabir U Ahmed; Suraia Nusrin; G Balakrish Nair; A K Siddique; R Bradley Sack; David A Sack; Anwar Huq; Rita R Colwell
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

Review 3.  Global dissemination of Vibrio parahaemolyticus serotype O3:K6 and its serovariants.

Authors:  G Balakrish Nair; Thandavarayan Ramamurthy; Sujit K Bhattacharya; Basabjit Dutta; Yoshifumi Takeda; David A Sack
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

4.  Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model.

Authors:  Shaghayegh Anvari; Shahin Najar-Peerayeh; Mehrdad Behmanesh; Bita Bakhshi
Journal:  Hum Vaccin Immunother       Date:  2018-06-19       Impact factor: 3.452

Review 5.  Circulation and transmission of clones of Vibrio cholerae during cholera outbreaks.

Authors:  O Colin Stine; J Glenn Morris
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

6.  Molecular evidence that a distinct Vibrio cholerae O1 biotype El Tor strain in Calcutta may have spread to the African continent.

Authors:  C Sharma; A Ghosh; A Dalsgaard; A Forslund; R K Ghosh; S K Bhattacharya; G B Nair
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

7.  Unique organization of the CTX genetic element in Vibrio cholerae O139 strains which reemerged in Calcutta, India, in September 1996.

Authors:  C Sharma; S Maiti; A K Mukhopadhyay; A Basu; I Basu; G B Nair; R Mukhopadhyaya; B Das; S Kar; R K Ghosh; A Ghosh
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

8.  Genetic diversity of Vibrio cholerae in Chesapeake Bay determined by amplified fragment length polymorphism fingerprinting.

Authors:  S C Jiang; V Louis; N Choopun; A Sharma; A Huq; R R Colwell
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

9.  Emergence and evolution of Vibrio cholerae O139.

Authors:  Shah M Faruque; David A Sack; R Bradley Sack; Rita R Colwell; Yoshifumi Takeda; G Balakrish Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

10.  New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh.

Authors:  G Balakrish Nair; Shah M Faruque; N A Bhuiyan; M Kamruzzaman; A K Siddique; David A Sack
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.